Close

Articles Posted in Product Liability

Updated:

Yaz, Yasmin & Ocella: Benefits Over Touted?

According to company e-mails, Bayer AG, Germany’s largest drugmaker, may have tried to market the Yasmin family of birth- control pills for unapproved uses and misled women about the health risks of the drugs. Bayer unit officials discussed promoting the contraceptive known as Yaz, a spinoff of Yasmin, for treatment…

Updated:

Dangerous Risks of Yaz Birth Control Side Effects

The steady drum beat of adverse medical reports and deadly side effects about the popular Yaz birth control pill and its variations continue to surface. Again another medical study has found that side effects of Yaz and Yasmin birth control increase the risk of a pulmonary embolism, deep vein thrombosis…

Updated:

Medtronic Infuse Bone Graft Cancer Concerns

According to the findings of a new medical study, presented at the North American Spine Society, Medtronic’s Infuse bone graft product maybe linked to an increased risk of cancer. There is growing concerns over a potential risk of cancer from Medtronic Infuse, which contains rhBMP-2, a bioengineered bone growth protein.…

Updated:

NuvaRing Risks Raises Venous Thromboembolic Events 56%

Medical data from a new FDA funded study indicates that the NuvaRing birth control may cause women to face a 56% higher risk of blood clots than those who take older birth control pills. NuvaRing is a female birth control device consisting of a medicated flexible ring. NuvaRing releases a…

Contact Us
Start Chat